China Pharma Holdings
CPHI
7 hedge funds and large institutions have $2.05M invested in China Pharma Holdings in 2014 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 2 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
46% more capital invested
Capital invested by funds: $1.41M → $2.05M (+$647K)
0% less ownership
Funds ownership: 0.02% → 0.02% (-0%)
22% less funds holding
Funds holding: 9 → 7 (-2)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$39.5K |
| 2 |
Renaissance Technologies
New York
|
+$3.04K |
| 3 |
VKH
Virtu KCG Holdings
New York
|
+$1.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FWSM
First Wilshire Securities Management
Pasadena,
California
|
-$32.6K |
| 2 |
CAM
Carret Asset Management
New York
|
-$10K |
| 3 |
PAM
Pope Asset Management
Memphis,
Tennessee
|
-$276 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PAM
1
Pope Asset Management
Memphis,
Tennessee
| $1.08M | -$276 | -1 | -0% |
|
|
FWSM
2
First Wilshire Securities Management
Pasadena,
California
| $718K | -$32.6K | -118 | -4% |
|
|
GA
3
Glenhill Advisors
New York
| $101K | – | – | – |
|
|
4
Renaissance Technologies
New York
| $80K | +$3.04K | +11 | +4% |
|
|
5
Citadel Advisors
Miami,
Florida
| $58K | +$39.5K | +143 | +163% |
|
|
VKH
6
Virtu KCG Holdings
New York
| $7K | +$1.1K | +4 | +17% |
|
|
PFO
7
Pathstone Family Office
Englewood,
New Jersey
| $4K | – | – | – |
|
|
CAM
8
Carret Asset Management
New York
| – | -$10K | -60 | Closed |
|
CPHI Hedge Fund Activity: Q1 2014 in Review
7 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in China Pharma Holdings (CPHI) for Q1 2014, worth a combined $2.05M — up 46% from $1.41M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of CPHI and 0 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 3 added.
The largest buyer was Citadel Advisors, adding an estimated $39.5K. The largest seller was First Wilshire Securities Management, cutting an estimated $32.6K.
- 7 institutional investors held China Pharma Holdings (CPHI) as of Q1 2014, down from 9 in Q4 2013.
- Funds reported $2.05M of China Pharma Holdings stock for Q1 2014, up 46% quarter-over-quarter.
- 0 funds opened new China Pharma Holdings positions in Q1 2014 and 2 closed out, a net change of -2 holders.
- The largest China Pharma Holdings buyer in Q1 2014 was Citadel Advisors, an estimated $39.5K added.
- The largest China Pharma Holdings seller in Q1 2014 was First Wilshire Securities Management, an estimated $32.6K sold.
Based on aggregated 13F filings for Q1 2014.